Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Central Retinal Vein Occlusion Patients Receiving Bevacizumab and Dexamethasone or Bevacizumab Only on Naive Eyes.

NCT04601701 is registered in ClinicalTrials.gov with He Eye Hospital as lead sponsor.

NCT NCT04601701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04601701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Central Retinal Vein Occlusion Patients Receiving Bevacizumab and Dexamethasone or Bevacizumab Only on Naive Eyes.
Lead sponsor
He Eye Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
October 17, 2020
Completion date
September 17, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central retinal vein occlusion